Global pharmaceutical companies are entering 2026 facing a high-stakes European drug pricing dispute as they seek to offset recent price concessions in the United States. Following intense pressure from President Donald Trump, who secured major drug price cuts for American patients in late 2025, companies are now turning to Europe to recoup revenue losses. Manufacturers such as Pfizer, Eli Lilly, and AstraZeneca have…
Tag: pharmaceutical innovation
-
A decade of transformation in obesity treatment
For long-time attendees of ObesityWeek, the 2024 conference in San Antonio felt markedly different. In the past, it was an intimate gathering of obesity specialists focused on research and clinical updates. However, as one physician noted, “There’s a lot more suits.” Wall Street has joined the event, drawn by the explosion of interest in the lucrative obesity treatment market. Since…